On 22 September 2022, an Order was made by the Grand Court of the Cayman Islands (“Grand Court”) (the “Order”) appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services (Cayman) Limited and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited as the Joint Provisional Liquidators of the Company (the “Joint Provisional Liquidators”). Upon the making of the Order, the powers of the directors of the Company are suspended. Blue Ocean Structure Investment Company Limited, a shareholder of the Company, filed a petition on August 22, 2022 in the Grand Court requesting the appointment.

Following the issuance of the Order, The New York Stock Exchange (the “NYSE”) halted trading in the Company's Ordinary Shares effective September 23, 2022.

Please click here for more information

Please click here for a copy of the JPLs' First Report to the Grand Court of the Cayman Islands

Please click here for a copy of the JPLs' Second Report to the Grand Court of the Cayman Islands

Please click here for a copy of the JPLs' Third Report to the Grand Court of the Cayman Islands

Please click here for a copy of the JPLs' Fourth Report to the Grand Court of the Cayman Islands

Please click here for a copy of the JPLs' Fifth Report to the Grand Court of the Cayman Islands

Please click here for a copy of the JPLs' Sixth Report to the Grand Court of the Cayman Islands

Please click here for a copy of the JPLs' Seventh Report to the Grand Court of the Cayman Islands

Please click here for a copy of the JPLs' Eighth Report to the Grand Court of the Cayman Islands

Please click here for a copy of the JPLs' Ninth Report to the Grand Court of the Cayman Islands

An extraordinary general meeting ("EGM") of Global Cord Blood Corporation (In Provisional Liquidation) (the "Company") will be held on 16 April 2024 at 07:45 Cayman Islands time (GMT-5). The EGM of the Company will be held for the purpose of considering and, if thought fit, passing resolutions in respect to the JPL's proposed terms of remuneration and the JPL's remuneration and disbursements for the period from 22 September 2022 to 30 September 2023. Further details regarding the proposals are set out in the i) Notice of EGM ii) Proxy Card iii) Proxy Statement and iv) Rules of Conduct. Note that only verified shareholders will be able to vote at the EGM.

i. On 13 May 2024, the JPLs filed a summons for court approval of the terms of their remuneration agreement and their remuneration for the Fee Approval Period pursuant to section 109(2) of the Companies Act and the Insolvency Practitioners' Regulations (2023 Consolidation) (the "Summons"). The Summons has been listed for hearing at 10am on 30 July 2024.
ii. Any shareholder who wishes to provide any additional comments or queries regarding the JPLs' proposed terms of remuneration and the JPLs' remuneration for the Fee Approval Period should do so in writing to the JPLs by no later than 1 July 2024. Any communications should be sent by email to [email protected].
iii. Any shareholder who intends to appear at the hearing of the Summons must notify the JPLs and confirm whether they support or oppose the orders being sought by no later than 9 July 2024 so as to ensure that the hearing of the Summons proceeds in an orderly manner. Click here to view this document.

On 18 July 2024, the JPLs issued correspondence to shareholders providing notice of an amendment to the Summons to seek Court approval of the proposed terms of remuneration. A sealed version of the amended summons was received from the Court Registry on 17 July 2024. Please Click Here to view this document.

The JPLs summons (as amended) was part-heard on 30 July 2024 and resulted in various orders by the Grand Court of the Cayman Islands. On 9 August 2024, a notice was issued to shareholders providing, inter alia, details of the outcome of the hearing, together with a copy of the Court orders. Please click here for a copy of the notice and the Court orders.

This website includes information and statements prepared by the pre-appointment Directors and Management of the Company and may be subject to change. The JPLs accept no responsibility for any errors, omissions, or misrepresentations contained on this website and make no assertions about the safety or effectiveness of any of the procedures described herein.